The cyclophosphamide equivalent dose as an approach for quantifying alkylating agent exposure: A report from the childhood cancer survivor study
Pediatric Blood & Cancer2013Vol. 61(1), pp. 53–67
Citations Over TimeTop 1% of 2013 papers
Daniel M. Green, Val Nolan, Pamela J. Goodman, John Whitton, Deo Kumar Srivastava, Wendy M. Leisenring, Joseph P. Neglia, Charles A. Sklar, Sue C. Kaste, Melissa M. Hudson, Lisa Diller, Marilyn Stovall, Sarah S. Donaldson, Leslie L. Robison
Abstract
The CED is easily calculated, facilitating its use for patient counseling. It is independent of the drug dose distribution of a particular patient population, a characteristic that will allow direct comparisons of outcomes among epidemiological cohorts. We recommend the use of the CED in future research assessing cumulative alkylating agent exposure.
Related Papers
- → AIC model selection using Akaike weights(2004)2,755 cited
- → Microcomputer-Based Nonlinear Regression Analysis of Ligand-Binding Data: Application of Akaike's Information Criterion(1986)37 cited
- → Using the corrected Akaike's information criterion for model selection(2017)7 cited
- → A modified akaike information criterion(1978)2 cited
- → Fitting a Gaussian Model to Aperture Synthesis Data by Akaike’s Information Criterion (AIC)(1979)1 cited